OREGON HEALTH & SCIENCE UNIVERSITY for OREGON HEALTH & SCIENCE UNIVERSITY
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); Inclusion of language to support research of PKAN, a rare inherited degenerative disorder, in a future appropriations bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXA DAMIS-WULFF New | — |
| MICHAEL HARRISON | — |
| ABIGAIL TIBBS | — |
Immigration IMM
H1B visa issues affecting Medical Students and permanent resident applications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXA DAMIS-WULFF New | — |
| MICHAEL HARRISON | — |
| ABIGAIL TIBBS | — |
Pharmacy PHA
Support for 340b Drug Discount Program for safety net hospitals and Health Resources and Services Administration
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXA DAMIS-WULFF New | — |
| MICHAEL HARRISON | — |
| ABIGAIL TIBBS | — |
Health Issues HCR
Adequacy of health care workforce associated with expansion of health care coverage; issues related to health care coverage; POLST issues; Issues related to allocation of Livers; S. 348 Resident Physician Shortage Reduction Act of 2019; Title VII and VIII; Nursing workforce development programs; support for hospitals and hospital workforce in context of COVID-19 pandemic, within the Coronavirus Aid, Relief, and Economic Security Act, H.R. 748 and the Paycheck Protection Program and Health Care Enhancement Act, H.R. 266.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXA DAMIS-WULFF New | — |
| MICHAEL HARRISON | — |
| ABIGAIL TIBBS | — |
Medicare/Medicaid MMM
Medicare support for Medicare Graduate Medical Education; Preventing reductions to the Medicaid program; Hospital Outpatient Prospective Payment and Ambulatory Payment Systems and Quality Reporting Programs, CMS-1695-P;Medicaid Fiscal Accountability Regulation (MFAR),CMS-2393-P; Medicare Accelerated Payment Program and Advance Payment Program;
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXA DAMIS-WULFF New | — |
| MICHAEL HARRISON | — |
| ABIGAIL TIBBS | — |
Education EDU
Inclusion of an emergency fund for academic health centers in future COVID relief legislation; the unique higher education needs of academic medical centers in training health care professionals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXA DAMIS-WULFF | — |
Animals ANI
Animal Welfare Act and Horse Protection Act; issues related to the use of animals in biomedical research; S. 3780 Kitten Act; H.R. 2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 3055, Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXA DAMIS-WULFF New | — |
| MICHAEL HARRISON | — |
| ABIGAIL TIBBS | — |
Medical/Disease Research/Clinical Labs MED
Use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tired with additional review in post-market; FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; FDA regulation of laboratory developed test; support for increased testing capacity to meet the demand posed by the COVID-19 pandemic; support for increase testing supplies to conduct coronavirus diagnostic tests; congressional support for FDA Emergency Use Authorization for OHSU 3D Printed CRISIS Ventilator; increased funding for federal research agencies in the Paycheck Protection Program and Health Care Enhancement Act, H.R. 266 and future pandemic relief legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXA DAMIS-WULFF New | — |
| MICHAEL HARRISON | — |
| ABIGAIL TIBBS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.